American Century Companies
CRMD icon

American Century Companies’s CorMedix CRMD Stock Holding History

American Century Companies’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$179K Buy
+26,402
New +$195K ﹤0.01% 2727

Other funds holding CRMD

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies's CRMD Position: Q1 2026 in Review

American Century Companies opened a new position in CorMedix (CRMD) in Q1 2026: 26,402 shares worth $179K. The stake represents ﹤0.01% of the portfolio and ranks #2727 among its holdings.

187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.

  • American Century Companies held 26,402 shares of CorMedix worth $179K as of Q1 2026.
  • CorMedix was a new American Century Companies position in Q1 2026.
  • CorMedix made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2727 holding.
  • 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.